Biotech Acquisition Co
NASDAQ:BIOT
Biotech Acquisition Co
Net Income (Common)
Biotech Acquisition Co
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Biotech Acquisition Co
NASDAQ:BIOT
|
Net Income (Common)
-$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WP Carey Inc
NYSE:WPC
|
Net Income (Common)
$573.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Starwood Property Trust Inc
NYSE:STWD
|
Net Income (Common)
$433.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Net Income (Common)
-$482.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Net Income (Common)
$1.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Net Income (Common)
-$341.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
See Also
What is Biotech Acquisition Co's Net Income (Common)?
Net Income (Common)
-6.9m
USD
Based on the financial report for Dec 31, 2021, Biotech Acquisition Co's Net Income (Common) amounts to -6.9m USD.
What is Biotech Acquisition Co's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-68 546%
Over the last year, the Net Income (Common) growth was -68 546%.